Quote | Oasmia Pharmaceutical AB - ADR (OTCMKTS:OASMY)
Last: | $0.02 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $0.02 |
High: | $0 |
Low: | $0 |
Volume: | 42 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Oasmia Pharmaceutical AB - ADR (OTCMKTS:OASMY)
Kazia Therapeutics (KZIA) has granted worldwide exclusive rights to develop and commercialize Cantrixil (TRX-E-002-1) to Oasmia Pharmaceutical AB (OASMY) targeting all indications, with an initial focus on ovarian cancer.Under the terms of the agreement, the Swedish biotech firm wil...
Message Board Posts | Oasmia Pharmaceutical AB - ADR (OTCMKTS:OASMY)
Subject | By | Source | When |
---|---|---|---|
Effective April 8,2022 Oasmia Pharmaceutical AB ADR will | Renee | investorshub | 04/07/2022 12:31:06 PM |
$OASM changed to $OASMY. Delisted from the Nasdaq | Renee | investorshub | 08/21/2019 10:32:50 PM |
* * $OASM Video Chart 07-05-2019 * * | ClayTrader | investorshub | 07/05/2019 9:01:08 PM |
Oasm $1.61 | stock1ace1 | investorshub | 04/16/2018 5:12:02 PM |
Oasmia Pharmaceutical Announces Positive Overall Survival Results from | LearnToTrade | investorshub | 04/27/2016 11:43:13 AM |